SCHEMBL6097515

SCHEMBL6097515

CC(C)Oc1ccc(-c2ccc(Cl)cc2)cc1C=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 8/20 0.51
MAPT P10636 3/20 0.41
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ADRB1 P08588 1/20 0.40
ADRB3 P13945 1/20 0.40
FFAR4 Q5NUL3 1/20 0.39
DRD2 P14416 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
DRD3 P35462 1/20 0.39
HTR6 P50406 1/20 0.39
MAP4K4 O95819 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
CNR1 P21554 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30933788 0.87 ERN1 (0.47) ERN1MAPTALDH1A1KDM4EHTR2A
SCHEMBL4209586 0.87 ERN1 (0.47) ERN1MAPTALDH1A1KDM4EHTR2A
SCHEMBL8322837 0.84 ALDH1A1 (0.56) ERN1MAPTALDH1A1KDM4EMEN1
SCHEMBL6098469 0.82 ERN1 (0.45) ERN1MAPTALDH1A1KDM4EMEN1
SCHEMBL6098103 0.78 ERN1 (0.55) ERN1MAPTALDH1A1KDM4EMEN1
SCHEMBL6097520 0.77 ERN1 (0.50) ERN1MAPTALDH1A1KDM4EMEN1
SCHEMBL5622410 0.75 ERN1 (0.48) ERN1MAPTALDH1A1KDM4EMEN1
SCHEMBL6930848 0.75 ALDH1A3 (0.53) ERN1MAPTALDH1A1KDM4EKMT2A
SCHEMBL14785211 0.74 ERN1 (0.44) ERN1ALDH1A1KDM4EHTR2AHTR2C
SCHEMBL6091203 0.74 ERN1 (0.57) ERN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7067535-B2 5-Phenylbenzylamine compounds, process for their production and intermediates for their synthesis TANABE SEIYAKU CO., LTD. (JP) 2006-06-27 US disclosed
US-20040097548-A1 5-Phenylbenzylamine compounds, process for their production and intermediates for their synthesis TANABE SEIYAKI CO., LTD. (JP) 2004-05-20 US disclosed
EP-1323713-A1 5-PHENYLBENZYLAMINE COMPOUNDS, PROCESS FOR THEIR PRODUCTION AND INTERMEDIATES FOR THEIR SYNTHESIS TANABE SEIYAKU CO., LTD. (JP) 2003-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097548-A1 5-Phenylbenzylamine compounds, process for their production and intermediates for their synthesis CYP1B1, MAOB, HTR1B ERN1 1413/4885MAPT 3253/4885ALDH1A1 136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.